FDA advisers to weigh risks of Abbott’s dissolving stent

[admin]

(Reuters) - U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.



More...